How point-of-care hemoglobin A1c routinely available in a clinic setting affects glycemic control

Point of Care

Volumn 7, Issue 2, 2008, Pages 72-75

  Petersen, John R ^a   Finley, Jane B ^a   Okorodudu, Anthony O ^a   Mohammad, Amin A ^a   Bajaj, Mandeep ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67650125644     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e318175d633     Document Type: Article

References (21)

1. World Health Organization. 2004. Global strategy on diet, physical activity and health: diabetes. Available at: http://www.who.int/hpr/ gs.fs.diabetes.shtml. Accessed December 19, 2006.
2. Centers For Disease Control. 2006. National Diabetes fact sheet: general information. Available at: http://www.cdc.gov/diabetes/pubs/ estimates05.htm#deaths. Accessed December 19, 2006.
3. Centers for Disease Control. National Center for Health Statistics. Fast stats: diabetes. Available at: http://www.cdc.gov/diabetes/pubs/ estimates05.htm#incidence. Accessed December 19, 2006.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N EnglJ Med. 1993;329:977-986.
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
6. ADA. Clinical practice recommendations. Diabetes Care. 2006; 29(suppl 1):S1-S85.
7. American Association of Clinical Endocrinologists Medical Guideline for the Management of Diabetes Mellitus. Available at: http://www.aace.com/pub/pdf/ guidelines/diabetes-2002.pdf. Accessed September 6, 2006.
8. National Institute for Clinical Excellence. Management of type 2 diabetes-managing blood glucose levels. Available at: http://www. nice.org.uk/page.aspx?o=36737. Accessed September 6, 2006.
9. Canadian Diabetes Association. Clinical practice guidelines. Clinical practice guidelines 2003 for the prevention and management of diabetes in Canada 2003. Available at: http://www.diabetes.ca/cpg2003/ chapters.aspx. Accessed June 6, 2006.
10. National Institute for Clinical Excellence. Management of type 2 diabetes-managing blood glucose levels. Available at: http://www. nice.org.uk/page.aspx?o=36737. Accessed June 6, 2006.
11. 1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care. 1999;22:1785-1789.
12. 1c measurements enhances clinical decision-making. Diabetes Care. 1999;22: 1415 -1421.
13. Grieve R, Beech R, Vincent J, et al. Near patient testing in diabetes clinics: appraising the costs and outcomes. Health Technol Asst. 1999;3:1-74.
14. 1c results on treatment decisions in office practice. Endocr Pract. 2001;7:85-88.
15. 1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care. 2003;26:1158-1163.
16. 1c. Diabetes Care. 2007;30:713-715.
17. 1c on glycemic control in patients with type 2 diabetes. Diabetes Care. 2006;29:1-8.
18. 1c Study). Diabetes Technol Ther. 2005;7:907-912.
19. Guerci B, Durain D, Leblanc H, et al. Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study Group. Diabetes Metab. 1997;23:195-201.
20. Evidence based practice for POCT. The National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines. Available at: http://www.aacc.org/AACC/members/nacb/LMPG/ OnlineGuide/DraftGuidelines/EB-for- POCT2004/. Accessed December 19, 2006.
21. Sayadah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.